what is the difference between compound semaglutide and wegovy Compounded “Semaglutide” vs Wegovy® (semaglutide) 2.4 mg injection Not all GLP-1s are created

Chem Res Toxicol 33(11):2699

O, 25.95 BPC-157 (Body Protection Compound-157) is a bioactive pentadecapeptide that exerts its effects through multiple complementary mechanisms, primarily involving modulation of the nitric oxide (NO) signaling pathway, upregulation of angiogenic factors such as VEGF, and activation of key cell survival and repair pathways including FAKpaxillin and MAPK signaling

These are all based on clinical trials

Acknowledgments We thank Frontiers in Molecular Biosciences for their invitation to publish our manuscript

Besides their antioxidant properties, polyphenols also exhibit antitumor properties [21]